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Abstract
Purpose—In contrast to other US racial/ethnic groups, Asian Americans (AA) have experienced 
steadily increasing breast cancer rates in recent decades. To better understand potential 
contributors to this increase, we examined incidence trends by age and stage among women from 
seven AA ethnic groups in California from 1988 through 2013, and incidence patterns by subtype 
and age at diagnosis for the years 2009 through 2013.
Methods—Joinpoint regression was applied to California Cancer Registry data to calculate 
annual percentage change (APC) for incidence trends. Incidence rate ratios were used to compare 
rates for AA ethnic groups relative to non-Hispanic whites (NHW).
Results—All AA groups except Japanese experienced incidence increases, with the largest 
among Koreans in 1988–2006 (APC: 4.7, 95% CI: 3.8, 5.7) and Southeast Asians in 1988–2013 
(APC: 2.5, 95% CI: 0.8, 4.2). Among women younger than age 50, large increases occurred for 
Vietnamese and other Southeast Asians; among women over age 50, increasing trends occurred in 
all AA ethnic groups. Rates increased for distant stage disease among Filipinas (2.2% per year, 
95% CI: 0.4, 3.9). Compared to NHW, Filipinas and older Vietnamese had higher incidence rates 
of some HER2+ subtypes.
Conclusions—Breast cancer incidence rates have risen rapidly among California AA, with the 
greatest increases in Koreans and Southeast Asians. Culturally-tailored efforts to increase 
awareness of and attention to breast cancer risk factors are needed. Given the relatively higher 
rates of HER2-overexpressing subtypes in some AA ethnicities, research including these groups 
and their potentially unique exposures may help elucidate disease etiology.
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INTRODUCTION
Over the last 15 years, breast cancer incidence has remained stable or declined in most US 
populations defined by race/ethnicity (1). However, among Asian Americans (AA), 
incidence has been increasing steadily, at 1.1% from 2003–2012 (1, 2). The AA category is 
heterogeneous, comprising populations from nearly 30 countries, and differing widely in 
migration patterns, socioeconomic status, health behaviors, and culture (3–5), all of which 
contribute to differences in disease incidence (6). Indeed, for breast cancer incidence, 
research including eight AA populations showed inter-ethnic variation in rate trends over the 
period 1990–2008, with annual increases ranging from 1.2% among Chinese and 
Vietnamese to 4.7% among Koreans, but stable rates for Japanese (7). Moreover, several 
studies have shown that rates in AA women differ by age and nativity, with higher rates 
among young US-born AA women (8–10). Rapidly increasing incidence rates also have 
been noted in Asian countries, and international data suggest that among more recent 
generations, rates in Asian countries may be surpassing rates in the US, particularly those 
for white women (11).
Breast cancer incidence also varies by disease subtype defined by tumor expression of 
hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2), and 
knowledge is growing about the differential impact of risk factors on the incidence of these 
subtypes (12). Within California, proportionally more breast cancers expressed HER2 
relative to HR+/HER2- in Korean, Filipino, Vietnamese, and Chinese women than in non-
Hispanic White (NHW) women (13). However, whether subtype-specific incidence rates 
differ across AA ethnicities is unknown.
Documenting breast cancer incidence trends among distinct AA populations has the 
potential to help us understand the observed overall increases, to better target prevention and 
screening efforts, and to guide further research into subtype-specific risk factors. Therefore, 
utilizing data from the population-based California Cancer Registry (CCR), in a state that is 
both the largest in US and has the most substantial population of Asian Americans (14), we 
examined breast cancer incidence patterns from 1988–2013 by detailed AA ethnic groups, 
age, and stage. For the most recent years of data from 2009–2013, we were also able to 
explore differences by age and subtype.
METHODS
Study data
Female invasive breast cancer incidence data (ICD-O-3 C50.0–50.9) were obtained from the 
CCR (comprising four National Cancer Institute Surveillance, Epidemiology and End 
Results (SEER) program registries) to analyze trends from 1988 through 2013. To examine 
the incidence patterns by both age and breast cancer subtypes, we focused on the most 
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recent 5-year data (2009 through 2013). We excluded 670 breast sarcomas (histology codes 
8800–8801, 8805, 8815, 8830, 8850, 8858, 8890, 8935, 8980, 8982–8983, 9120, 9180–
9181, and 9260 (15)). Patient information included race/ethnicity, stage, and age at 
diagnosis, routinely reported to the registry. We examined AA as a single group and then by 
seven major AA ethnicities: Chinese, Japanese, Korean, Filipino, Vietnamese, South Asians 
(Asian Indians and Pakistanis), and Southeast Asians (Cambodians, Laotians, Hmong, Thai). 
Comparison data were drawn for non-Hispanic whites (NHW).
For each breast cancer, we obtained data on subtype classified based on pathology report 
review regarding expression of estrogen receptor (ER) and/or progesterone receptor (PR), 
which are commonly combined for defining HR status, and HER2. HR positivity is based on 
positive status for ER and/or PR. HER2 has been reported to the CCR since approximately 
2000, although data are more complete and clinically relevant (given availability of targeted 
treatment) in recent years. Subtype analyses focused on the period 2009–2013 and excluded 
the 11% of breast cancers with unknown ER, PR, and/or HER2 status; the percentages of 
tumors missing subtype information were similar for AA and NHW. Annual population 
counts by race/ethnicity were estimated using linear interpolation and extrapolation of 1990, 
2000, and 2010 Census counts.
Statistical analysis
We calculated annual cancer incidence rates as cases per 100,000 persons, age-adjusted to 
the 2000 US standard population, using SEER*Stat software (16). Joinpoint regression 
models were used to calculate annual percent change (APC) for each AA ethnicity and 
NHW, for all ages combined and by age group (younger than age 50 (“younger”), ages 50 
and over (“older”)). To accommodate the smaller annual case counts in analysis of data by 
disease stage, we used three-year cumulative rates for determining stage-specific APCs for 
each AA ethnicity and for NHW (17, 18).
Incidence rate ratios (IRRs) and 95% confidence intervals (CI) were computed relative to 
NHW for 1988–2013 overall and for 2009–2013 by breast cancer subtype (HR+/HER2−, 
HR+/HER2+, HR−/HER2+, triple-negative (HR-/HER2-, “TNBC”)). A maximum of five 
joinpoints was allowed based on single-year data. APCs were considered statistically 
significant if the associated 95% CI excluded zero.
RESULTS
Incidence trends 1988–2013
From 1988 through 2013, 548,259 new invasive breast cancer cases were diagnosed in 
California women, including 383,478 in NHW and 45,721 in AA. Compared to NHW 
women, AA women as a group experienced a larger incidence rate increase in breast cancer 
(APC: 2.4, 95% CI: 1.2, 3.6 from 1988–1998, compared to 0.8 (0.5–1.1) from 1988–2001 
among NHW) (Figure 1). Whereas rates for NHW women fluctuated between 1998 and 
2013, rates for AA women increased modestly (APC: 0.6, 95% CI: 0.1, 1.0). Breast cancer 
incidence increased significantly in all AA ethnicities except Japanese over the 26-year 
period. The largest increases occurred among Koreans from 1988 through 2006 (APC: 4.7, 
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95% CI: 3.8, 5.7) and Southeast Asians from 1988 through 2013 (APC: 2.5, 95% CI: 0.8, 
4.2). From 1988 through 2013, small incidence increases were noted for Chinese (APC: 1.1, 
95% CI: 0.7, 1.5), Filipinas (APC: 1.1, 95% CI: 0.7, 1.4), South Asians (APC: 1.4, 95% CI: 
0.7, 2.1), and Vietnamese (APC: 1.3, 95% CI: 0.7, 1.9).
Among younger (<50 years) AA women (Figure 2a), incidence increases occurred over time 
for all groups except Japanese, Filipinas, and South Asians. For younger women, increases 
in incidence were observed among Koreans from 1988 through 2006 (APC: 3.9, 95% CI: 
2.7, 5.1), Vietnamese from 1988 through 2013 (APC: 1.4, 95% CI: 0.7, 2.1), and Southeast 
Asians from 1988 through 2013 (APC: 2.0, 95% CI: 0.6, 3.5).
Among older women (Figure 2b), rates increased across all AA ethnic groups, notably 
among Japanese in 1988 through 1998 (APC: 3.9, 95% CI: 1.0, 6.8), Koreans in 1988 
through 1997 (APC: 11.1, 95% CI: 6.2, 16.1) and South Asians in 1990 through 1996 (APC: 
12.7, 95% CI: 0.1, 26.9). Incidence rates among older Japanese and NHW women were 
generally stable in more recent years.
Considering stage at diagnosis, incidence increases occurred among AA combined primarily 
for localized (APC: 1.4, 95% CI: 0.8, 1.9) and distant stage (APC: 1.4, 95% CI: 0.1, 2.8) 
disease; rates were stable for regional stage, and decreased for unstaged tumors (APC: −4.7, 
95% CI: −6.4, −2.9) (Table 1). Localized stage increases from 1988–1990 through 2012–
2013 occurred annually (APC) among Chinese (1.6%), Japanese (3.2% for 1998–1990 
through 1997–1999), Filipinas (1.4%), South Asians (1.9%), Vietnamese (2.1%), and 
Southeast Asians (3.1%). For regional stage disease, annual increases occurred among 
Koreans (5.8% for 1988–1990 to 2003–2005) and South Asians (0.6%). Distant stage 
increases were significant among Filipinas (2.2%) and non-significant for Koreans and 
South Asians (4.1% and 2.6%, respectively).
Incidence rate ratios (relative to NHW) by age and subtype, 2009 through 2013
During the time period 2009–2013, overall incidence rates were statistically significantly 
lower among AA women than NHW women. The only exception was observed among 
younger Japanese and Filipino women, who had rates very similar to those of similarly aged 
NHW (Japanese IRR: 1.02, 95% CI: 0.91, 1.14; Filipino IRR: 0.95, 95% CI: 0.90, 1.01) 
(Table 2).
Among all women, the most common breast cancer subtype was HR+/HER2− (Table 2). 
Incidence rates of HR+/HER2− were significantly lower for all AA groups than for NHW 
women; the exception was for young Japanese women (IRR: 1.18, 95% CI: 1.04, 1.35). For 
all racial/ethnic groups, the lowest rates occurred for the HR−/HER2+ subtype; nevertheless, 
rates were 20% higher in AA than NHW women (IRR for all ages: 1.21, 95% CI: 1.12, 
1.30). Among younger women, Filipinas had the highest incidence of HR−/HER2+, with 
rates significantly higher than NHW women (IRR: 1.79, 95% CI: 1.44, 2.22). Among older 
women, HR−/HER2+ rates were significantly higher among Filipinas (IRR: 1.48, 95% CI: 
1.29, 1.69) and Vietnamese (IRR: 1.39, 95% CI: 1.12, 1.73) than NHW.
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For the HR+/HER2+ subtype, incidence rates were significantly lower in all AA ethnic 
groups than in NHW women, except for Filipinas, whose rate was significantly higher (IRR: 
1.15, 95% CI: 1.05, 1.25).
For TNBC, the rate among AA ethnicities combined was significantly lower than NHW 
women (IRR: 0.61, 95% CI: 0.58, 0.65). However, young South Asian women and older 
Japanese women had rates similar to those in NHW women.
DISCUSSION
This report provides new insights into the epidemiology of breast cancer among the most 
prominent AA ethnic groups in California. Using 26 years of surveillance data, we found 
that breast cancer incidence has risen rapidly among AA women, in contrast to declines 
reported in California and nationwide (1) among NHW. Rates increased across all seven AA 
ethnic subgroups, particularly among Koreans and Southeast Asians, the groups with the 
lowest absolute rates. Although breast cancer incidence rates in AA women combined were 
lower than rates for NHW, the rates for Japanese and Filipinas under age 50 were 
comparable to rates for similarly aged NHW women. We found particularly rapid rate 
increases among older Koreans and South Asian women during the 1990s, although these 
increases slowed in more recent years. While increases occurred for localized stage disease, 
the more substantial rate increases in distant stage, particularly among Filipino, Korean, and 
South Asian women, were concerning, albeit not statistically significant in the latter two 
groups.
Using US cancer registry data, DeSantis et al. reported a 1.5% annual increase in breast 
cancer incidence among Asian/Pacific Islander women as a combined group from 2008 
through 2012 (1). This trend contrasts with stable or declining trends among other racial/
ethnic groups, but is similar to increasing trends in South Korea, China, Taiwan, Japan, and 
Hong Kong. In age-period-cohort analyses, Sung et al. (11) and Wang et al. (19) found 
dramatically increasing trends of breast cancer incidence (11) and mortality (19) in recent 
cohorts in Asia, with incidence rates through 2009 surpassing those of US NHW women 
(11). These authors attributed increases to increasing prevalence among Asian women of 
established reproductive breast cancer risk factors.
Although prior research has examined subtype-specific incidence patterns among Asians/
Pacific Islanders as an aggregate group, ours is the first examination of subtype-specific 
incidence patterns among AA ethnicities, unmasking the heterogeneity among AA ethnic 
groups. We found that AA women in California generally had lower rates of the HR+/
HER2−, HR+/HER2+, and TNBC subtypes relative to NHW women; exceptions were the 
higher rates of HR+/HER2− cancer among younger Japanese women and of HR+/HER2+ 
cancers among Filipino women. In addition, Filipino and Vietnamese women had higher 
rates of HR−/HER2+ breast cancer than NHW women, and Chinese women had rates 
comparable to those of NHW women. These patterns are consistent with the higher 
proportional odds of HR−/HER2+ tumors relative to HR+/HER2− tumors among AA than 
NHW in this population (13, 20). Using SEER data from 2010 forward, Kohler et al. 
reported lower breast cancer rates in Asian/Pacific Islander women than NHW women, with 
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the exception of higher HR−/HER2+ incidence in Asian/Pacific Islander women (21). Most 
studies have found that socioeconomic status, body mass index, and reproductive factors are 
related mainly to the HR+ cancers (12, 22–25), with less evidence of associations with the 
rarer subtypes, such as HR−/HER2+ cancers (12). However, in a recent examination of 
subtype differences and several reproductive factors in an ethnically diverse group of women 
with breast cancer, Chen et al. found that higher parity increased risk for 
HER2−overexpressing tumors (26).
Although California’s population comprises 32% of all US AA, our results may not be 
generalizable to AA populations in other geographic areas. Misclassification of ethnicity 
could bias our findings, although misclassification in AA ethnicity is fairly minimal in 
cancer registry data (27, 28), and surname- and nativity-based algorithms are routinely 
applied to classify cases that are “Asian, not otherwise specified” into specific AA ethnic 
groups. The proportion of cases with unknown subtype was relatively high, primarily due to 
unknown HER2 status; this could have resulted in under-estimation of subtype-specific 
rates. In addition, subtype classification based on immunohistochemical assays commonly 
used in pathology labs may differ from subtypes classified based on gene expression 
profiling (29, 30).
When breast cancer incidence was examined for women from specific AA ethnicities, 
several noteworthy patterns emerged. These included continuing increases in rates of breast 
cancer among women from all seven AA ethnic groups, with the largest increases for South 
Asians, Vietnamese, and Southeast Asians – the most recently immigrated groups; rates 
among Japanese and Filipino women under age 50 comparable to those in NHW women; 
increasing trends over time of distant stage disease, particularly among Filipino, Korean, and 
South Asian women; and higher rates of some types of HER2−overexpressing tumors 
among Filipino and Vietnamese women relative to NHW women. These patterns warrant 
additional attention to public health prioritization of disparities in access to care, as well as 
further research in identifying relevant breast cancer risk factors. In particular, studies should 
investigate risk factors, perhaps early-life exposures, underlying the higher rates of breast 
cancer among young Filipino and Japanese women, with attention to possible genetic 
susceptibility. Further, increasing trends of late stage disease suggest a need for higher rates 
of mammography screening in these populations. Mammography utilization rates in 
California are slightly lower in Asian American women than in NHW, NHBs and Hispanics 
(31), and among the AA ethnic groups, Korean and South Asian women have the lowest 
mammography utilization, consistent with their higher rates of distant stage disease (31, 32). 
The disproportionately high rates of some HER2-overexpressing subtypes also require better 
understanding, as this subtype tends to grow more quickly, spread more aggressively, and 
present more often as high-grade disease than the more common HR+/HER2- tumors (12). 
Further evaluation is needed to assure that these groups are properly treated with targeted 
trastuzumab treatment. As little is known regarding risk factors for these breast cancer 
subtypes, studies that include these ethnic groups and their potential unique exposures may 
provide insights into their etiology. This research highlights the value and insights gained 
from considering distinct AA ethnicities in breast cancer research. Future research should 
always aim to disaggregate AAs given their heterogeneous incidence patterns.
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Incidence rates over time of invasive breast cancer among Asian American ethnic groups 
and non-Hispanic Whites, 1988–2013, California.
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Incidence rates over time of invasive breast cancer among Asian American ethnic groups 
and non-Hispanic Whites, 1988–2013, California
a. ages <50 years
b. ages 50+ years
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Table 1
Invasive breast cancer incidence rates and annual percent change (APC) by stage for Non-Hispanic Whites 
(NHW) and Asian American (AA) ethnic group, 1988–2013, California
Stage Ethnic Group Years* APC (95% CI) 2009–2013 Incidence Rate (per 100,000)
Localized Non-Hispanic White 1988–1990 to 2012–2013 0.1 (−0.5, 0.6) 91.4 (90.6, 92.2)
All Asian Americans 1988–1990 to 2012–2013 1.4 (0.8, 1.9) 60.6 (59.4, 61.9)
Chinese 1988–1990 to 2012–2013 1.6 (1.0, 2.2) 57.3 (55.1, 59.7)
Japanese 1988–1990 to 1997–1999 3.2 (0.3, 6.3)
78.7 (73.9, 83.9)
1997–1999 to 2012–2013 −0.1 (−1.2, 1)
Filipino 1988–1990 to 2012–2013 1.4 (0.9, 1.9) 72.1 (69.5, 74.7)
Korean 1988–1990 to 2006–2008 4.9 (2.5, 7.3)
41 (37.8, 44.5)
2006–2008 to 2012–2013 −2.1 (−13.7, 11.1)
South Asian 1988–1990 to 2012–2013 1.9 (0.7, 3.2) 57.4 (53, 62)
Vietnamese 1988–1990 to 2012–2013 2.1 (1.4, 2.9) 50.2 (46.8, 53.8)
Southeast Asian 1988–1990 to 2012–2013 3.1 (0.3, 5.9) 32.5 (28.1, 37.3)
Regional
Non-Hispanic White 1988–1990 to 2012–2013 −0.3 (−1, 0.3) 39.4 (38.8, 40)
All Asian Americans 1988–1990 to 2000–2002 2.3 (0, 4.7)
27.4 (26.5, 28.2)
2000–2002 to 2012–2013 −0.5 (−2.2, 1.4)
Chinese 1988–1990 to 2012–2013 0.6 (−0.4, 1.5) 24 (22.6, 25.6)
Japanese 1988–1990 to 2012–2013 0.3 (−0.8, 1.4) 30.1 (27, 33.4)
Filipino 1988–1990 to 2012–2013 0.8 (−0.1, 1.8) 34.7 (32.9, 36.5)
Korean 1988–1990 to 2003–2005 5.8 (2.4, 9.3)
19.8 (17.6, 22.3)
2003–2005 to 2012–2013 −1.4 (−6.7, 4.2)
South Asian 1988–1990 to 2012–2013 0.6 (0.1, 1.1) 32 (28.8, 35.4)
Vietnamese 1988–1990 to 2012–2013 0.4 (−1, 1.8) 21.4 (19.3, 23.8)
Southeast Asian 1988–1990 to 2012–2013 2.4 (−0.1, 4.9) 16.5 (13.3, 20.2)
Distant
Non-Hispanic White 1988–1990 to 2000–2002 −1.3 (−2.3, −0.4)
6.9 (6.7, 7.2)
2000–2002 to 2012–2013 2.4 (1.3, 3.6)
All Asian Americans 1988–1990 to 2012–2013 1.4 (0.1, 2.8) 4.1 (3.8, 4.4)
Chinese 1988–1990 to 2012–2013 −0.1 (−2, 1.9) 3 (2.5, 3.6)
Japanese 1988–1990 to 2012–2013 1.3 (−1.4, 4.1) 4.1 (3, 5.4)
Filipino 1988–1990 to 2012–2013 2.2 (0.4, 3.9) 5.7 (5, 6.4)
Korean 1988–1990 to 2012–2013 4.1 (−1.3, 9.9) 3.3 (2.5, 4.4)
South Asian 1988–1990 to 2012–2013 2.6 (−0.8, 6.1) 5.2 (4, 6.8)
Vietnamese 1988–1990 to 2012–2013 0.1 (−1.6, 1.9) 3.2 (2.4, 4.2)
Southeast Asian 1988–1990 to 2012–2013 1.9 (−4.4, 8.6) 2.8 (1.6, 4.5)
Unstaged
Non-Hispanic White 1988–1990 to 2012–2013 −4.9 (−6.0, −3.9) 2.0 (1.9, 2.1)
All Asian Americans 1988–1990 to 2012–2013 −4.7 (−6.4, −2.9) 1.2 (1.1, 1.4)
Chinese 1988–1990 to 2012–2013 −5.1 (−7.4, −2.7) 1.1 (0.8, 1.5)
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Stage Ethnic Group Years* APC (95% CI) 2009–2013 Incidence Rate (per 100,000)
Japanese 1988–1990 to 2012–2013 −4.2 (−7.0, −1.4) 1.3 (0.7, 2.1)
Filipino 1988–1990 to 2012–2013 −5.5 (−8.8, −2.2) 1.5 (1.2, 1.9)
Korean 1988–1990 to 2012–2013 −2.3 (−6.3, 1.8) 1.7 (1.1, 2.5)
South Asian 1988–1990 to 2012–2013 −3.3 (−7.6, 1.3) 1.1 (0.6, 1.8)
Vietnamese 1988–1990 to 2012–2013 −3.2 (−8.3, 2.2) 0.9 (0.5, 1.6)
Southeast Asian 1988–1990 to 2012–2013 −0.8 (−8.3, 7.3) 0.8 (0.3, 1.9)
Bolded text indicates a significant APC.
*
Three-year cumulative incidence rates were used to calculate APC, except for 2012–2013.
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